Board Change • Jul 02
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Graham Cooley was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Jul 01
Gelion plc Announces Board Changes, Effective June 30, 2026 Gelion plc had announced that John Wood stepped down from the Board, effective June 30, 2026. John Wood will continue to support Gelion as a Senior Advisor, assisting Matt Wood and the executive team with the continuity of key relationships, partnerships and corporate knowledge. Matt Wood joined the Board with immediate effect on June 30, 2026. Matt's appointment reflects the Group's current transition from a technology development organisation to a business focused on commercial scale-up. Matthew Wood, aged 44, is a UK national who, after six years at BP, has spent the bulk of his career with Boston-based Cabot Corporation (NYSE: CBT), a global specialty chemicals company producing carbon- and silica-based specialty materials for a range of industries including automotive and battery. In his 15 years with Cabot, he occupied a number of leadership positions including Vice President Global Marketing & Strategy, Battery Materials and, most recently, Senior Vice President & President, Reinforcement Materials. His roles included postings to Germany and China as well as the US where he lived until recently. Matt Wood has held P&L accountability for businesses ranging from USD 10 million to USD 2 billion revenue. He is a results-driven business leader who has delivered rapid growth in complex and challenging markets with a track record of scaling industrial manufacturing businesses, including battery materials and managing partnerships with global players in Japan, Europe and the US. Matthew Forster Wood (aged 44) holds or has held the following directorships or partnerships in the last five years: Current Directorships /Partnerships: None. Former Directorships /Partnerships within last five years: Applied Nanostructured Solutions, LLC; Cabot (China) Limited; Cabot Australia Holdings Pty. Ltd.; Cabot Corporation; Cabot International Capital Corporation; Cabot Japan K.K.; Cabot Specialty Chemicals Mexico S.A.P.I. de C.V. Board Change • May 20
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Graham Cooley was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Feb 11
Gelion plc to Report First Half, 2026 Results on Mar 02, 2026 Gelion plc announced that they will report first half, 2026 results on Mar 02, 2026 Annuncio • Dec 05
Gelion plc Achieves Target Areal Capacity in Coin Cells Gelion plc has achieved a major technical milestone in the development of its next-generation sulfur battery technology. This achievement marks a major step forward in Gelion's roadmap to delivering high-energy-density, low-cost sulfur-based batteries suitable for e-aviation, electric mobility, stationary storage, and other commercial applications. In this next phase of development, Gelion confirms that its proprietary cathode active material ("Gelion CAM") has crossed the Fourth Quarter threshold demonstrating stable cycling with the industry recognised Fourth Quarter areal capacity (~4 mAh/cm2) in coin cells, the industry standard platform for evaluating new battery materials. Achieving Fourth Quarter is widely regarded as a key milestone for high energy density sulfur cathodes. This demonstrates that Gelion CAM can be processed into thicker, high structural integrity electrodes which provide a critical step towards high energy density performance in large format pouch cells. This is a critical enabler for scaling sulfur-based technology toward commercial grade battery systems. Building on the successful technology transfer from the Max Planck Institute of Colloids and Interfaces (MPI) and the Gelion CAM scale-up announced in September 2025, recent electrode development work shows that Gelion's proprietary material can maintain mechanical stability and controlled porosity even at increased thickness. Achieving these properties is critical to reaching industrially relevant high-areal-capacity electrodes and represents an important benchmark for competitiveness with conventional lithium-ion technology. Historically, increasing sulfur loading in battery electrodes has been limited by rapid degradation of thicker electrodes. Gelion's results indicate that its CAM can overcome these limitations, supporting higher energy per square centimetre while maintaining electrode robustness, a key pathway toward smaller, lighter, and higher-energy battery cells. Achieved Fourth Quarter areal capacity is a core technical requirement for large-format Li-S and Na-S cells and directly supports Gelion's energy-density and cost objectives for next-generation sulfur-based batteries. Key Highlights: Fourth Quarter Achieved in Coin Cells: Gelion has successfully reached its Fourth Quarter areal-capacity target in coin-cell testing, the industry-recognised standard for evaluating advanced battery materials. Fourth Quarter is widely recognised as a critical milestone for practical high-energy-density sulfur cathodes. Clear Technical Progress Toward Pouch Cells: The coin-cell results provide strong evidence supporting the translation of Gelion's CAM into large-format pouch-cell electrodes capable of meeting Fourth Quarter performance targets. Improved Electrode Quality and Consistency: Recent work demonstrates enhanced uniformity, improved adhesion, and reproducible slurry rheology, all compatible with scale-up for larger-format electrodes. Enabling Future High Energy Density Targets: This milestone strengthens Gelion's roadmap toward high-energy-density, high-cost sulfur-based batteries appropriate for e-aviation, Electric mobility, stationary storage, and Other commercial applications. Annuncio • Nov 27
Gelion plc, Annual General Meeting, Dec 22, 2025 Gelion plc, Annual General Meeting, Dec 22, 2025. Location: the companys registered office, level 4 ldnw, 3 noble street, ec2v 7ee, london United Kingdom Annuncio • Nov 25
Gelion plc to Report Fiscal Year 2025 Results on Nov 27, 2025 Gelion plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Nov 27, 2025 Annuncio • Oct 22
Gelion plc has completed a Follow-on Equity Offering in the amount of £0.5 million. Gelion plc has completed a Follow-on Equity Offering in the amount of £0.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 2,500,000
Price\Range: £0.2
Transaction Features: Regulation S Annuncio • Oct 21
Gelion plc has completed a Follow-on Equity Offering in the amount of £10.5 million. Gelion plc has completed a Follow-on Equity Offering in the amount of £10.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 50,000,000
Price\Range: £0.2
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 2,500,000
Price\Range: £0.2
Transaction Features: Regulation S; Subsequent Direct Listing Annuncio • Oct 17
Gelion plc has filed a Follow-on Equity Offering in the amount of £10.5 million. Gelion plc has filed a Follow-on Equity Offering in the amount of £10.5 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 50,000,000
Price\Range: £0.2
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,500,000
Price\Range: £0.2
Transaction Features: Regulation S; Subsequent Direct Listing Annuncio • Apr 23
Gelion plc has completed a Follow-on Equity Offering in the amount of £0.177466 million. Gelion plc has completed a Follow-on Equity Offering in the amount of £0.177466 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,971,845
Price\Range: £0.09 Annuncio • Mar 14
Gelion plc to Report First Half, 2025 Results on Mar 19, 2025 Gelion plc announced that they will report first half, 2025 results on Mar 19, 2025 Annuncio • Feb 26
Gelion plc Announces Successful Grant of Three LiS Patents in the U.S Gelion announced the successful award of three patents in the United States in relation to the Group's core Lithium-Sulfur (LiS) technology and the acceptance of one of its recycling patent applications by the United States Patent and Trademark Office (USPTO). Gelion continues to actively pursue, focus, and strengthen its Intellectual Property (IP) portfolio in accordance with its IP Strategy. Gelion's IP strategy includes an ongoing review and assessment of its IP portfolio, of both registered (e.g. patents) and unregistered (e.g. know-how, trade secrets) IP rights to ensure that the Group's IP portfolio continues to align and best protect the key areas of its technology as it matures, with a goal to develop a strong IP portfolio while delivering value for its shareholders. LiS patents granted Gelion has successfully advanced several patent applications pertaining to its core LiS technology, including the granting of three cases in the United States since July 2024. In parallel, Gelion continues to pursue its recycling IP portfolio, with one application recently being accepted in the United States. This application outlines an approach for improving the purity of high-value metals (e.g. nickel, cobalt) recovered from the waste batteries by providing a method for the removal of iron impurities. The Group expects progression of the application in the U.S. will strengthen applications in other major markets, including Europe and China, in line with Gelion's IP strategy to have broad protection of its IP portfolio in key markets globally. Gelion is currently developing its recycling technology with funding support from the UK government, and continues to explore commercialisation opportunities, including securing independent funding in accordance with its strategic plan. Gelion's Recycling IP portfolio now includes 9 patent families (with cases both granted and under examination). Gelion is developing a GEN 3 Lithium Sulfur cell product for its high energy density sulfur cathode at its expanded R&D facilities in Australia and UK, enabling it to integrate with a variety of anodes ranging from graphite to silicon to lithium metal, depending on the targeted application. Gelion's GEN 3 cell is unlocking the potential of sulfur batteries for a wide range of global mobile applications including electrical vertical-take-off-and-landing (eVTOL), drone markets, electric vehicles (EVs) and stationary energy storage (ESS). Advantages of Gelion's GEN 3 Lithium SulfUR - High energy density - Energy density > 400 Wh/kg, when using a 10+ Ah pouch cell. Semi-solid-state /Solid-State as a route to increased longevity/cycle life: GEN 3 employs a semi-solid-state and solid-state mechanism which mitigates the major degradation factor associated with conventional Li-S technology. Increased sulfur utilisation: GEN 3 demonstrates the full theoretical capacity of sulfur, i.e. a much higher sulfur utilisation than found in conventional Li-S approaches. Simplified supply chain: The innovative cathode is produced by mixing commercially available materials with abundant sulfur using a low-energy, room-temperature process, with potential to eliminate the need for pre-fabrication of the sulfur composite (sulfur composite is related to cathode active material in conventional lithium-ion batteries), streamlining the associated supply chain and production process and enabling localised manufacturing. Environmental and economic benefits: The water-based, standard-atmosphere cathode production process eliminates the need for toxic solvents, leading to significant cost savings and enhanced manufacturability. Glossary 1MPa This level of pressure replicates real-world pressure conditions inside batteries and is crucial for ensuring the durability, efficiency, and performance of the separator in practical applications. Cycle life indicates longer-lasting performance. Gelion is adapting its zinc technology to comprise an alternate cathode technology, a zinc hybrid cell to develop complementary next-generation batteries for the lead-acid eco-system. Early testing indicates that this solution has the potential to maintain good energy density levels with enhanced cost and safety aspects. Once fully-lasting performance. Annuncio • Jan 06
Gelion plc Announces Appointment of Dr Graham Cooley as Non-Executive Director and Member of Audit Committee and Remuneration Committee Gelion plc announced the appointment of Dr Graham Cooley as Non-Executive Director and member of Audit Committee and Remuneration Committee of the Company with immediate effect. Dr Cooley's appointment strengthens the Company's capabilities and corporate governance for the next stage of its growth. Dr Graham Cooley brings a wealth of relevant experience and knowledge to the Gelion Board through his background in the power, energy storage and hydrogen sectors over more than 35 years. He was previously Business Development Manager at National Power plc, the UK's largest power generator, and CEO of ITM Power plc, the first hydrogen related company quoted on AIM. Dr Cooley has been involved in a wide range of corporate transactions, including ones that have raised over £600m for UK cleantech SMEs. He also has a track record of forging industrial partnerships and entering new markets. He has been an active investor in AIM UK cleantech companies for over a decade and holds a PhD in Materials Physics, an MBA and has several fellowship appointments. Dr Cooley has been appointed as a member of the Company's Audit Committee and Remuneration Committee. Dr Graham Edward Cooley, aged 61, Current directorships and/or partnerships: Light Science Technologies Holdings plc; Brigantia Capital Ltd; Cadent Gas Limited;Cap-XX Limited; Quadgas Holdco Limited; Quadgas Investments Bidco Limited; Quadgas Midco Limited; Quadgas Pledgeco Limited; Yelooc Limited; LSTH Trustee Limited; Light Science Technologies Ltd; Tomtech (UK) Limited; LSTH IFB Limited; UK Circuits and Electronics Solutions Limited; UK Circuits and Electronics Solutions Holdings Limited; Quadgas Holdings Topco Limited (UK); Quadgas Holdings Topco Limited (Jersey). Past directorships and/or partnerships (within the last five years): ITM Power plc; H2 Green Ltd; ITM Power UK Limited (formerly ITM Power (Trading) Limited); ITM Power Pty Limited; ITM Linde Electrolysis GmbH; ITM Power ApS; ITM Power Service GmbH; ITM Service GmbH; ITM Power (Shelfco) Limited; ITM Power (Research) Limited; Motive Fuels Limited; Nanosun Limited; Orkney Hydrogen Trading Ltd; Renewable UK Association. Annuncio • Nov 14
Gelion plc Produces Solid-State Separator Suitable for Li-S and Li-NMC Batteries Via Oxford University's Breakthrough Technology Gelion plc announced it has successfully fabricated advanced sulfide-based solid-state separators utilising the novel Intellectual Property (IP) licensed from Oxford University Innovation Limited (Oxford University). This result enables Gelion to proceed to the next stage of optimization for this separator which has the potential to not just increase the cycle life of existing lithium metal batteries but also for Gelion's high energy density GEN 3 lithium-sulfur (LiS) cells. Solid Electrolyte Separators (SES) are recognized as a key enabler to long duration high energy lithium metal batteries due to their potential to increase safety, cycle life and energy density of battery technologies in which they are employed. Their implementation has been hampered due to challenges in their processability and manufacture and this successful fabrication is an important step to solving these challenges. Significantly, these advancements: introduces another potential revenue stream by way of licensing to Lithium nickel manganese cobalt oxides (Li-NMC) battery manufacturers, when optimized to enable scaled production of the SES; facilitate the incorporation of SES into liquid-based Li-metal (e.g., Li-NMC and Lithium-air (Li-air) battery technologies), Li-S and solid-state Li-ion/Li-S cell assembly; relax the operational requirements (i.e. external pressure and temperature) of solid-state batteries that comprise this SES technology making this technology more viable for commercialization. New Risk • Oct 13
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 28% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.7m). Market cap is less than US$100m (€30.1m market cap, or US$32.9m). Annuncio • Aug 15
Gelion Announces an Update on Its Next Generation Lithium-Sulfur (Li-S) Battery Development Gelion announces an update on its Next Generation ("GEN 3") Lithium-Sulfur (Li-S) battery development. Building on the announcements made in March and April 2024, Gelion has now successfully developed 1 Ah semi-solid-state Li-S pouch cells with its GEN 3 cell technology. The Company's modelling from these 1 Ah GEN 3 cells predicts that a 10 Ah cell can be expected to deliver energy density greater than 400 Wh/kg. Gelion's GEN 3 technology uses a unique sulfur cathode material (fabricated using a unique, low energy process carried out at room temperature), water-based cathode processing (non-toxic), and a proprietary liquid electrolyte. The GEN 3 platform is based on a specially engineered formulation of commercially available materials in combination with abundant sulfur to demonstrate high energy density and operational temperature capability. Benefits of Gelion's GEN 3 over GEN 2 · Higher energy density -Energy density expected to be greater than 400 Wh/kg, when using a 10 Ah pouch cell. · Increased longevity/cycle life: GEN 3 employs new sulfur chemistry to increase stability, addressing the major degradation factors associated with conventional Li-S technology. · Increased sulfur utilisation:GEN 3 demonstrates the full theoretical capacity of sulfur, i.e. a much higher sulfur utilisation than found in conventional Li-S approaches. · Simplified supply chain:The innovative cathode combines specially engineered, but commercially available, materials with abundant sulfur that are produced using a low-energy, room-temperature process, eliminating the need for pre-processing, streamlining the battery production process and enabling localised manufacturing. Environmental and economic benefits:The water-based, atmospheric cathode production process eliminates the need for toxic solvents, leading to significant cost savings and enhanced manufacturability. GEN 3 uses the extensive network of Li-S technologies developed within Gelion and contained in the patents acquired from Johnson Matthey in March 2023. The GEN 3 semi-solid-state Li-S cell builds on the GEN 2 Li-S cell (developed by OXIS Energy) and addresses the key barriers to commercialisation faced by typical lithium-sulfur developers. Sulfur, being an abundant material, offers a future not limited by geographically concentrated and controlled battery metals. However, other lithium-sulfur developers often require the use of hard to obtain, rare or costly materials and have to rely on high-energy and time-consuming processes. Gelion's GEN 3 platform and production process circumvents these barriers. The GEN 3 cell is designed to tolerate higher operational temperatures by using Gelion's proprietary 'SulfurLock electrolyte' - which is free from temperature-sensitive additives typically found in Li-S batteries. Additionally, this electrolyte has been engineered to prevent sulfur redistribution during operation, increasing cycle life, addressing the primary cause of degradation in Li-S batteries. Gelion's cathode uses a proprietary sulfur active cathode material, fabricated using a unique, low energy process performed at room temperature. By using this process, Gelion can eliminate the need to pre-fabricate the cathode-active material. This has the potential to simplify the battery supply chain and make the production of sulfur batteries not only easier, but also more cost efficient than is the case for lithium-ion batteries, enhancing the manufacturing options geographically. New Risk • Jul 01
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£9.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£9.2m free cash flow). Share price has been highly volatile over the past 3 months (33% average weekly change). Earnings have declined by 28% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.6m). Market cap is less than US$100m (€35.6m market cap, or US$38.2m). New Risk • May 07
New major risk - Revenue and earnings growth Earnings have declined by 28% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 28% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-UK£9.2m). Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.6m). Market cap is less than US$100m (€26.9m market cap, or US$29.0m). Annuncio • Apr 04
Gelion Announces Update on Its Next Generation Lithium-Sulfur (Li-S) Battery Development Gelion announced an update on its Next Generation Lithium-Sulfur (Li-S) battery development. Gelion has achieved a high energy density milestone by fabricating a 395 Wh/kg lithium-sulfur 9.5 Ah pouch cell (commercial cell format). This result represents a c. 60% increase in the energy density (lower weight) compared with current lithium-ion batteries (approximately 250 Wh/kg). Further to the announcement on 19 March 2024, Gelion had produced 1.0 Ah cells using the OXIS Gen2 cell technology that achieved energy density of 245 Wh/kg. The achievement of 395 Wh/kg aligns with the independent energy density modelling projections for a larger cell format. Achievement of this milestone represents a key technology proof point for Gelion. By re-establishing this performance, building on the OXIS Gen 2 technology and IP acquired from Johnson Matthey. The Company has set a new benchmark against which to compare upcoming 'Next Generation' cell which targets further performance improvements upon this announced result. On 19 March 2024, Gelion identified that testing of Next Generation cell technology is exhibiting expected solid-to-solid conversion (see Glossary)behaviourtoward enhanced stability and longevity. will continue to progress these developments in addition to the silicon-sulfur cell technology in cooperation with Ionblox. Gelion's ambition for its next generation platform is to unlock the potential of sulfur batteries for a wide range of global applications including electric vertical-takeoff-and-landing (eVTOL) aircraft, drones, electric vehicles (EV), and stationary energy storage (ESS), as high Wh/kg translates to lighter batteries and opens many advantages for these markets. Sulfur being an abundant material offers a future not limited by geographically concentrated and controlled battery metals which significantly improves battery lifecycle sustainability. In May 2023, Gelion updated on the progress made using the battery technology package acquired from Johnson Matthey (containing, in addition to its own IP, the Li-S IP and know-how from OXIS Energy). Gelion has worked over the past nine months to benchmark, improve on, and define a next generation approach to Li-S battery development. Li-S batteries are an advanced alternative to Li-ion batteries that can achieve much greater gravimetric energy densities (measured as amount of energy per battery weight). This is critical to drive down the weight in mobile applications such as EV's, e-aviation, and drones, reducing auxiliary component cost and lessening their upfront environmental impact. They do not contain rare metals in the cathode and can be scaled to meet the demands of global electrification. The technology shows promise to be safer (lower risk of fires) than current batteries. Annuncio • Mar 21
Gelion plc to Report First Half, 2024 Results on Mar 27, 2024 Gelion plc announced that they will report first half, 2024 results on Mar 27, 2024 Annuncio • Feb 05
Gelion plc Announces Board Appointments Gelion plc announced the appointment of Dr. Louis Adriaenssens as Chief Technological Officer (CTO) of the company and Dr. Adrien Amigues as President of Gelion UK and Europe, with immediate effect. Louis joins Gelion with exceptional experience in specialist battery innovation, manufacture and commercialisation, having most recently worked in Nevada as the Supervisor of Chemistry for Panasonic at the Tesla Gigafactory, where he and his team looked after the processes associated with the production of approximately 5 million battery cells per day. A contributing author/inventor of leading scientific articles and significant patents across the fields of materials chemistry, electrochemistry and synthesis, Louis will lead a technical team of over 20 PhD or graduate level engineers and scientists, across Australia and the UK stewarding a portfolio including 470 patents in 76 patent families (including new patents under application). The appointment of a CTO comes at a pivotal time in the development of Gelion's Lithium-Sulfur (LiS) and Zinc-based (Zn) battery technologies and operational expansion into the UK and Europe. This follows the acquisition of OXLiD Ltd. in November 2023, whose founder Dr. Adrien Amigues will now take up the role of President of Gelion UK and Europe. Gelion founder and Principal Technology Adviser, Professor Thomas Maschmeyer, will continue with all his leadership contributions and governance roles within the Group. New Risk • Jan 02
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (UK£8.5m net loss in 3 years). Shareholders have been diluted in the past year (26% increase in shares outstanding). Revenue is less than US$5m (UK£2.1m revenue, or US$2.6m). Market cap is less than US$100m (€38.2m market cap, or US$41.8m). Annuncio • Nov 25
Gelion plc has completed a Follow-on Equity Offering in the amount of £4.491206 million. Gelion plc has completed a Follow-on Equity Offering in the amount of £4.491206 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,875,000
Price\Range: £0.24
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 16,838,358
Price\Range: £0.24
Transaction Features: Regulation S Annuncio • Nov 11
Gelion plc has filed a Follow-on Equity Offering in the amount of €4 million. Gelion plc has filed a Follow-on Equity Offering in the amount of €4 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 16,666,667
Price\Range: €0.24 Annuncio • Nov 10
Gelion plc (AIM:GELN) signed an agreement to acquire Oxlid Ltd for £4.2 million. Gelion plc (AIM:GELN) signed an agreement to acquire Oxlid Ltd for Approximately £4.2 million on November 9, 2023.Cavendish Capital Markets Limited acted as financial advisor to Gelion plc (AIM:GELN). New Risk • Oct 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 45% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (6.6% average weekly change). Revenue is less than US$5m (UK£1.7m revenue, or US$2.1m). Market cap is less than US$100m (€30.7m market cap, or US$32.4m). Annuncio • Aug 15
Gelion plc Provides Revenue Guidance for Year Ended 30 June 2023 Gelion plc provided revenue guidance for year ended 30 June 2023. For the year the company expected to be ahead of current guidance: Revenues for the year are expected to be £2.0 million ahead of current guidance of £1.7 million. Annuncio • Jul 06
Gelion plc Updates on the Strategic Evaluation of Its Zinc Battery Solution and on Advances Made on Its Lithium Sulfur Technology Gelion plc provided an update on the strategic evaluation of its Zinc battery solution and on advances made on its Lithium Sulfur technology. The Company's match to market analysis to define the operational parameters of Gelion's zinc bromide ('ZnBr 2') battery highlighted the need to balance three key priorities - safety, energy density and cost and consistent with this, the 12-month ZnBr 2 research programme ("R&D Programme") was launched earlier this year. Strong early progress has been made on the anode side, with significantly improved zinc plating behaviour, achieving improved system behaviour (reducing and potentially eliminating the need to fully discharge the battery periodically for maintenance), however, the R&D Programme also identified potential safety concerns on the cathode side, arising from efficacy of the approach of sequestering bromine in the battery. Gelion continued R&D for the cathode, and it has now identified and is migrating to a zinc solution that avoids the potential safety concerns arising from sequestering bromine. Successful validation is expected to result in a technology with safety, energy density and cost ambitions achieved at the same time. Gelion expects to validate the potential of this technology over the next six months and report back in early 2024, keeping in line with the timelines communicated for the current R&D Programme. Management believes that this solution is highly desirable to Gelion's end market and will accelerate Gelion's ability to scale-up into commercial production. Lithium Sulfur: Management is encouraged by the progress being made toward realising the potential of intellectual property packages acquired from Johnson Matthey when combined with Gelion's existing technologies. Gelion therefore intends to increase the testing capacity of its research and development facilities in this regard by 50%. Based in Sydney, the site will have the capability to increase Gelion's prototyping toward cell development and is due to be operational in September 2023. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Joycelyn Morton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Nov 09
Gelion plc, Annual General Meeting, Dec 09, 2022 Gelion plc, Annual General Meeting, Dec 09, 2022. Annuncio • Oct 21
Gelion plc to Report Fiscal Year 2022 Results on Nov 09, 2022 Gelion plc announced that they will report fiscal year 2022 results on Nov 09, 2022 Breakeven Date Change • Jul 01
Forecast to breakeven in 2025 The analyst covering Gelion expects the company to break even for the first time. New forecast suggests the company will make a profit of UK£100.0k in 2025. Average annual earnings growth of 56% is required to achieve expected profit on schedule. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Joycelyn Morton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 14
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Joycelyn Morton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 
